Dateline: Mon, 06 Feb 2006
freeNewsArticles Story Summary: “COLUMBUS, OH – Feb. 6 (SEND2PRESS NEWSWIRE) — PHIS, Inc. announced today the availability of its novel wide-spectrum homeopathic remedy, CarcinPLUS(TM), a single remedy made from the blood of a breast cancer donor who was taking several notable natural supplements to assist in treating her cancer. This type of homeopathic remedy is classified as a ‘nosode’ according to the FDA and is available by prescription only. Nosodes are created from the diseased tissue of an organism using the basic homeopathic principal of ‘like treating like.’ The history of this practice stems from 1830 when Constantine Hering was the first to consider the use of nosodes.”
A R T I C L E:
CarcinPLUS(TM) is a unique homeopathic remedy that combines the effectiveness of Carcinosin with the added component of a potent natural supplement “cocktail” that was “processed” by a human donor.
COLUMBUS, OH (SEND2PRESS NEWSWIRE) — PHIS, Inc. announced today the availability of its novel wide-spectrum homeopathic remedy, CarcinPLUS(TM), a single remedy made from the blood of a breast cancer donor who was taking several notable natural supplements to assist in treating her cancer. This type of homeopathic remedy is classified as a “nosode” according to the FDA and is available by prescription only. Nosodes are created from the diseased tissue of an organism using the basic homeopathic principal of “like treating like.” The history of this practice stems from 1830 when Constantine Hering was the first to consider the use of nosodes.
While testing is underway to determine the exact mechanism of action of CarcinPLUS(TM), early results in both humans and animals suggest the remedy may provide some positive effects for a wide variety of conditions. Several case studies are listed on the Company’s website at www.carcinplus.com. In addition, the website provides links to published references describing the known effects of the supplements being taken by the CarcinPLUS(TM) donor, which may account for the early positive results being observed in those using the remedy.
Recent studies on similar homeopathic remedies have reported impressive results in both preventing and treating cancers. A 2005 study published in the Journal of Alterative and Complementary Medicine on Carcinosin, also a nosode created from breast cancer tissue, demonstrated that when administered orally to mice chronically fed a carcinogenic agent that induces liver cancer, the remedy provided antitumoric, anticlastogenic, and anticytotoxic effects.
A 2003 article in the International Journal of Oncology on one of the supplements taken by the CarcinPLUS donor was conducted at M.D. Anderson Cancer Center in Texas and also at a homeopathic clinic in India. In this study, 6 of the 7 glioma [brain cancer] patients showed complete regression of tumors. Both in vivo and in vitro results showed induction of survival-signaling pathways in normal lymphocytes and induction of death-signaling pathways in brain cancer cells.
In the United States about 20 million to 30 million people use homeopathic remedies, according to Peter Gold, communications director of the National Center for Homeopathy in Alexandria, Va., “Worldwide, the number is staggering,” he says. “In Europe alone, 40 percent to 50 percent of consumers use them.” (Progressive Grocer, Dec. 2005). One of the most pervasive reasons for the boon in homeopathy and other alternative products is that consumers have indicated their desire for health care solutions that are less intrusive, have fewer side effects, and are more focused on prevention.
More information: www.carcinplus.com
###
Copyright © 2006 by PHIS, Inc. and Send2Press® Newswire, a service of Neotrope® – all rights reserved. Information believed accurate but not guaranteed. Sourced on: freeNewsArticles.com.
• Story Title: A New Twist In An Old Healing Dance
• REFERENCE KEYWORDS/TERMS: , , , , Health, Diet and Fitness, , , .
IMPORTANT NOTICE: some content which is considered “old” or “archival” may reference an event which has already occurred; some content possibly considered “advertorial” may also reference a promotion or time-limited/sensitive offering, and in all of these instances certain material may no longer be valid. For notably stale content, you should directly contact the company/person mentioned in the text (PHIS, Inc.); this site cannot assist you with information about products/services mentioned in the news article, nor handle any complaints or other issues related to any person/company mentioned or promoted in the above text. Information believed accurate but not guaranteed as of original date of story [Mon, 06 Feb 2006 10:57:00 GMT].
USE THIS CONTENT FOR FREE: To use this content in your newspaper, broadcast outlet, news portal, blog/ezine or similar, free of cost, CLICK HERE to learn how.